| 000 | 01083 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250515191128.0 | ||
| 264 | 0 | _c20091201 | |
| 008 | 200912s 0 0 eng d | ||
| 022 | _a1095-6859 | ||
| 024 | 7 |
_a10.1016/j.ygyno.2009.09.005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCadron, Isabelle | |
| 245 | 0 | 0 |
_aApplication of proteomics in ovarian cancer: which sample should be used? _h[electronic resource] |
| 260 |
_bGynecologic oncology _cDec 2009 |
||
| 300 |
_a497-503 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xblood |
| 650 | 0 | 4 |
_aProteomics _xmethods |
| 700 | 1 | _aVan Gorp, Toon | |
| 700 | 1 | _aTimmerman, Dirk | |
| 700 | 1 | _aAmant, Frederic | |
| 700 | 1 | _aWaelkens, Etienne | |
| 700 | 1 | _aVergote, Ignace | |
| 773 | 0 |
_tGynecologic oncology _gvol. 115 _gno. 3 _gp. 497-503 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ygyno.2009.09.005 _zAvailable from publisher's website |
| 999 |
_c19206625 _d19206625 |
||